Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Lamassu Pharma | 2025 | Grant | $2.7M | Durham |
| South Rampart Pharma | 2025 | Series A | $8.0M | New Orleans |
| InformAI | 2025 | Grant | $465K | Houston |
| HepaTx | 2025 | Grant | Undisclosed | Palo Alto |
| PhagePro | 2025 | Grant | $200K | Boston |
| Micro-Leads | 2025 | Grant | $100K | Somerville |
| Nanopath | 2025 | Grant | $100K | Cambridge |
| Therini Bio | 2025 | Series A | $39.0M | San Francisco |
| Hillhurst Biopharmaceuticals | 2025 | Grant | $6.3M | San Diego |
| Nuravax | 2025 | Grant | $3.0M | Irvine |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Lamassu Pharma | Grant | $2.7M | Durham, United States |
| 102 | South Rampart Pharma | Series A | $8.0M | New Orleans, United States |
| 103 | InformAI | Grant | $465K | Houston, United States |
| 104 | HepaTx | Grant | Undisclosed | Palo Alto, United States |
| 105 | PhagePro | Grant | $200K | Boston, United States |
| 106 | Micro-Leads | Grant | $100K | Somerville, United States |
| 107 | Nanopath | Grant | $100K | Cambridge, United States |
| 108 | Therini Bio | Series A | $39.0M | San Francisco, United States |
| 109 | Hillhurst Biopharmaceuticals | Grant | $6.3M | San Diego, United States |
| 110 | Nuravax | Grant | $3.0M | Irvine, United States |
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.
InformAI delivers AI-enabled clinical solution focused on oncology and diagnostic imaging to improve patient outcomes.
Hepatx is developing regenerative medicine solutions.
PhagePro is an early-stage biotechnology therapeutics company.
Micro-Leads Medical is a medical technology company dedicated to developing innovative therapies that address the neuromodulation.
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Nuravax develops and researches on vaccines, preventive solutions and treatment for neurodegenerative disorders.
Epicore Biosystems is a digital health solutions company that develops sweat-sensing wearables, providing personalized health insights.
Amissa powers evidence-based perimenopause care with AI-enabled clinical decision support.
GelSana Therapeutics develops novel advanced polymers to improve wound healing
Ria Health is an online platform providing telehealth services for alcohol use disorder.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Peel Therapeutics is a biotech company that develops medicines for cancer and inflammatory diseases.
Arcascope makes apps that utilize algorithms that track circadian rhythms and generates personalized recommendations.
Mustang Bio is a clinical-stage biopharmaceutical company .
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
IotaMotion is a medical technology company developing robotics-assisted solutions for cochlear implant surgery.
IVOS Medical is a startup medical device specializing company in airway management.
Rhealth is a biotechnology company that provides health management solutions based on advanced AI through a platform to hospitals.
Thetis Pharmaceuticals is a biopharmaceutical company.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
PhotoniCare is a medical device company that develops diagnostic tools to improve clinical outcomes and address unmet patient needs.
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Medical Device. The firm invests across 26 different industry categories.
Among tracked funding rounds, Therini Bio received $39.0M in a Series A round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include Lamassu Pharma, South Rampart Pharma, InformAI, HepaTx, PhagePro. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors